Summary GLP-1 receptor sensitivity naturally decreases after months of continuous stimulation, which explains why appetite suppression weakens over time even when you're taking medication as prescribed
A January 2025 study focused on nine patients taking semaglutide and tirzepatide, a similar drug
We excluded patients with bariatric surgery history and required weight measurements during baseline (90 days pre-treatment), the first year post-treatment (year 1), and the second year post-treatment (year 2), yielding 34,143 semaglutide-treated and 16,034 tirzepatide-treated patients ( Figure S1 )
If you're a clinically eligible adult researching compounded GLP-1 access in 2026, Trimi is worth a serious look
The solution is to equalize pressure before adding water
Semaglutide, the active ingredient in Ozempic, has also been shown to dramatically reduce pain in people with knee osteoarthritis, aid in drug and alcohol addiction recovery and lower the risk of heart attack or stroke